Omaxe Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on June 29 2021 inter-alia:
1. To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the Quarter & Financial Year ended on March 31 2021 and to adopt the Statutory Audit Report on the same at the recommendation of
the Audit Committee which will consider the same at its meeting scheduled to be held on the same day prior to the Board Meeting;
2. To consider the matter related to declaration of Dividend on it’s 0.1% Non-Cumulative Non-Convertible Redeemable Preference Shares and Final Dividend on Equity Shares if any for the Financial Year 2020-21 at the recommendation of
the Audit Committee;
Further in accordance with the applicable Regulations of SEBI (PIT) Regulations 2015 the “Trading Window” for dealing in Equity Shares of the Company was closed from April 01 2021 till 48 hours after the Standalone and Consolidated Audited
Financial Results are submitted to the Stock Exchanges i.e. till end of business hours on July 01 2021. The same has been intimated to all the Directors Promoters Auditors Key Managerial Personnel and Designated Personnel & their immediate relatives.